Medical Doctor Program year 2025 Reported 2023–2025 Source: CMS Open Payments, 2026 publication

Siddardth Umapathy

Pain Medicine Fort Eisenhower, GA Medical Doctor

NPI 1982166278 CMS profile 11462418

300 E Hospital Road, Pain Medicine Clinic, Fort Eisenhower, GA 30905

Open in the dashboard

General payments

$41,496

317 records reported · program years 2023–2025

Research payments

$0

Paid to them · None reported · program years 2023–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Siddardth Umapathy of Fort Eisenhower, GA is reported in the CMS Open Payments database as having received $41,496 across 317 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Pain Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

3 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $31,656 232
2024 General $8,373 72
2023 General $1,467 13

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Siddardth Umapathy
  • Pain Medicine median
  • Middle half of Pain Medicine
  • National median

In program year 2025, general payments to Siddardth Umapathy were reported at $31,656. Among 1,144 Pain Medicine profiles paid that year, the median was $402 and the middle half received between $130 and $1,173.

Show as a table
Year Siddardth Umapathy Pain Medicine median Middle half National median
2019 $0 $409 $115–$1,311 $163
2020 $0 $214 $66–$666 $114
2021 $0 $299 $84–$899 $132
2022 $0 $335 $103–$1,149 $149
2023 $1,467 $376 $114–$1,228 $160
2024 $8,373 $387 $115–$1,173 $164
2025 $31,656 $402 $130–$1,173 $169

Breakdown

Who paid General payments · program years 2023–2025
  1. BIOTRONIK NRO, Inc. $18,361 102 payments
  2. Medtronic, Inc. $8,298 82 payments
  3. Spinal Simplicity, LLC $3,157 32 payments
  4. Abbott Laboratories $2,881 17 payments
  5. Saluda Medical Americas, Inc. $2,425 9 payments
  6. Boston Scientific Corporation $1,596 16 payments
  7. MML US, Inc. $1,305 10 payments
  8. Nalu Medical, Inc. $961 8 payments
  9. SPR Therapeutics, Inc $879 23 payments
  10. Curonix LLC $452 6 payments
  11. Other $1,181 12 payments

Every payment, record by record

What the payments were for General payments · program years 2023–2025
  1. Food and Beverage $18,858 267 payments
  2. Travel and Lodging $12,407 47 payments
  3. Compensation for serving as faculty or as a speaker for a medical education program $10,212 2 payments
  4. Entertainment $19 1 payment
Products named General payments · program years 2023–2025
  1. Prospera $15,374 70 payments
  2. HA MINUTEMAN G3-R $3,077 31 payments
  3. INTELLIS ADAPTIVESTIM $2,958 26 payments
  4. Evoke $2,425 9 payments
  5. KYPHON EXPRESS II KYPHOPAK TRAY $2,394 19 payments
  6. PROCLAIM $2,108 10 payments
  7. INCEPTIV $1,667 25 payments
  8. ReActiv8 $1,305 10 payments
  9. VANTA ADAPTIVESTIM $1,227 11 payments
  10. Nalu Neurostimulation System $961 8 payments
  11. Other $4,575 69 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

317 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pain Medicine in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record